The Decline and Fall of The Monitor Empire
While we were recovering from our turkey-induced slumbers, we read the shocking news that Michael Porter's Monitor Group has filed for bankruptcy, and is being acquired by Delloitte . The…
While we were recovering from our turkey-induced slumbers, we read the shocking news that Michael Porter's Monitor Group has filed for bankruptcy, and is being acquired by Delloitte . The…
We've had the good fortune to work with a biosimilars client this year. Working in this space has given us an opportunity to read and listen to many experts in…
As we've done in the past, we've tabulated the countries of origin from the stack of business card collected at BIO Europe 2012. Our "rules" for this analysis are simple.…
We’ve returned from BIO Europe 2012 in Hamburg with a stack of business cards, pages of meeting notes, prioritized follow ups, and some great memories. We managed to completely fill…
Bruce Booth (yet again) published a terrific post on his blog, entitled "NextWave of Pharma Innovation?" His premise is that reformulations, like the once-daily liquid methylphenidate product, Quillivant XR, is not…